1. SPICKS100
2. lindas0529
3. rustyratrod
4. mwelz917
5. dkid8231
1.mwelz917 06/05/2018
Dynavax (DVAX) Stock Is Undervalued with 88% Upside Potential, Says Cowen
2.rustyratrod 06/04/2018
Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
3.lindas0529 04/23/2018
Dynavax's HEPLISAV-B® ACIP Recommendations Published in the CDC's Morbidity and Mortality Weekly Report
4.SPICKS100 01/09/2018
News Link Posted:
5.SPICKS100 03/09/2018
Dynavax Technologies Corporation (DVAX) Draws a Price Target Hike on Back of Big Short-Term Upside Prospects
6.SPICKS100 09/12/2017
Nice gains!
7.lindas0529 02/14/2018
Sold some today $DVAX.
8.SPICKS100 02/21/2018
Dynavax's HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults
9.SPICKS100 03/27/2018
Dynavax Technologies (DVAX) Poses Bullish Risk/Reward into Upcoming SD-101 Data
10.lindas0529 05/08/2018
ER
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW